Technology is redefining the boundaries of clinical care through digital& AI-augmented respiratory care. From digital spirometry and smart inhalers to remote oxygen saturation monitoring and virtual pulmonary rehab platforms, patients are becoming active participants in their disease management. AI-driven tools are now assisting in radiographic interpretation, symptom tracking, and predictive analytics for exacerbation risk. Digital & AI-Augmented Respiratory Care is transforming not only diagnostics and treatment adherence but also provider workflows, enabling earlier interventions and better resource allocation. Integration with electronic health records and wearable biosensors is creating a continuous feedback loop between patient and clinician. Challenges around data privacy, standardization, and digital literacy remain, but the potential to democratize respiratory care across diverse populations is unprecedented. The path forward involves evidence-based integration of digital tools into mainstream respiratory practice.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation